The Philippines' top news stories from January 18 to 24, 2026The Philippines' top news stories from January 18 to 24, 2026

Top 5 News This Week: Frenchie Mae Cumpio, Sara Duterte, Bongbong Marcos, Weixiong Lin

2026/01/25 11:12

This week, we saw the biggest fish so far in the flood control corruption mess be arrested and jailed — deja vu for former senator Bong Revilla.

Complaints are filed against Vice President Sara Duterte and President Ferdinand Marcos Jr., stemming from alleged corruption. Journalist Frenchie Mae Cumpio is convicted of terrorism financing. Rappler uncovers Pharmally exec Weixiong Lin’s alleged drug and human trafficking ties.

These are the country’s top news stories from January 18 to 24, 2026.

Find out more about them:

#5 Bong Revilla to be detained at Quezon City Jail over flood control case + Brice Hernandez, Jaypee Mendoza detained at Quezon City Jail with Bong Revilla

#4 Sara Duterte faces new set of plunder, graft complaints over confidential funds

#3 First impeachment complaint vs Marcos faults him for ICC arrest of Duterte + Marcos faces second impeach complaint, leftists say House ‘blocked’ receipt

#2 Journalist Frenchie Mae Cumpio convicted of terror financing

#1 Pharmally boss Lin Weixiong entangled in Asia Pacific crime web + Taiwan drug convict poses as Filipino, links to Pharmally boss Lin Weixiong

Watch the video for a quick roundup of these stories. – Rappler.com

Presenter, producer: JC Gotinga
Video editor: Jen Agbuya
Supervising producer: Beth Frondoso

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.